To date, the role of CPET (cardiopulmonary exercise testing) for risk stratification in elderly patients with HF (heart failure) with depressed or preserved ventricular function has not been evaluated. In the present study, we analysed whether CPET is useful in predicting outcome in this population. A total of 220 NYHA (New York Heart Association) class I-III patients with HF 70 years of age [median age, 75 years; 23 % had NYHA class III; and 59 % had preserved ventricular systolic function (left ventricular ejection fraction 40 %)] performed maximal CPET (peak expiratory exchange ratio > 1.00). Median peak oxygen uptake was 11.9 ml · kg −1 of body weight · min −1 , medianVE/VCO 2 slope (slope of the minute ventilation/carbon dioxide production ratio) was 33.2 and 45 % had an EVR (enhanced ventilatory response) to exercise (VE/VCO 2 slope 34). During 19 months of follow-up, 94 patients (43 %) met the combined end point of death and hospital admission for worsening HF, arrhythmias or acute coronary syndromes. By Cox multivariable analysis, a creatinine clearance of < 50 ml/min {HR (hazard ratio), 1.657 [95 % CI (confidence interval), 1.055-2.602]} and EVR [HR, 1.965 (95 % CI,] were the best predictors of outcome, while ventricular function had no influence on prognosis. In conclusion, in elderly patients with HF, a steeperVE/VCO 2 slope provides additional information for risk stratification across the spectrum of ventricular function and identifies a high-risk population, commonly not considered in exercise testing guidelines.
INTRODUCTION
HF (heart failure) is a common chronic disease in the elderly. Although relief of symptoms and acceptable quality of life are the main goals of treatment in frail patients with multiple disabling co-morbidities, 'robust' elderly subjects, with no relevant strength or mobility problems, may have an outlook similar to younger patients, and should be carefully assessed for up-to-date treatment.
When assessing prognosis in elderly patients with HF, certain predictors are particularly relevant in view of their prevalence in older age. Renal dysfunction, common in the elderly and frequent in HF, increases mortality across the whole spectrum of ventricular impairment [1, 2] . In the elderly, PLVEF {preserved LVEF [LV (left ventricular) ejection fraction}-HF is a common and costly clinical entity, with mortality and 1-year re-admission rates [3, 4] similar to SHF (HF with depressed systolic function). Increasing evidence links diastolic dysfunction to exercise intolerance [5] .
Among laboratory investigations, CPET (cardiopulmonary exercise testing) with gas exchange measurement, when technically feasible, is an accurate tool in routine clinical evaluation and risk stratification of patients with HF [6, 7] . ReducedVo 2peak [peakVo 2 (oxygen consumption)] and ventilatory abnormalities, such as an EVR (enhanced ventilatory response) to exercise provide an objective and non-invasive evaluation of functional capacity and have been shown to predict prognosis in a large subset of patients with SHF and PLVEF-HF [8] [9] [10] [11] . Our group has demonstrated previously the feasibility and safety of CPET in elderly patients with HF [12] .
BNP (brain natriuretic peptide), a composite marker of systolic and diastolic function, and neurohormonal activation, is a prominent prognostic parameter, even in elderly patients [13, 14] . Previous clinical reports have focused on the prognostic usefulness of BNP andVo 2peak in patients with HF [15, 16] ; however, CPET-derived parameters of ventilatory efficiency may be superior to BNP in predicting the prognosis of patients with SHF [17] .
The aim of our present study was to address the additive prognostic role of ventilatory parameters to clinical, neurohormonal and echocardiographic variables in stable elderly outpatients with mild-to-moderate SHF and PLVEF-HF on optimized medical treatment, followed-up at a dedicated HF clinic.
MATERIALS AND METHODS

Study population
Between October 2001 and January 2006, 331 consecutive outpatients aged 70 years with a diagnosis of HF of at least 3 months were screened for CPET evaluation, and 95 were excluded for the reasons detailed in Figure 1 . Patients were in NYHA (New York Heart Association) classes I-III on stable drug doses without worsening symptoms or in need of intravenous inotropic support during the last 4 weeks. Among the 236 consenting subjects who were able to perform a CPET test, 220 with aVo 2peak < 25 mg · kg −1 of body weight · min −1 and a RER (respiratory exchange ratio) > 1.00 at CPET, indicating the achievement of anaerobic exercise conditions, were enrolled; 16 subjects with an RER 1.00 were excluded.
The study protocol was approved by the Institutional Ethics Committee and complies with the ethical rules for human experimentation that are stated in the Declaration of Helsinki. Written informed consent was obtained from each patient.
Baseline laboratory assessment was performed according to standard laboratory methods. Creatinine clearance, as an estimate of GFR (glomerular filtration rate), was determined using the Cockcroft-Gault equation [17a] .
Patients were followed up in the outpatient HF clinic of our hospital. Outcome data of patients who did not attend their scheduled appointments (< 10 % of those enrolled) were obtained by telephone interview of the patient or his/her family; none of these patients had been admitted to hospital. The primary combined study end point was defined as the occurrence of death and hospital admission for worsening HF, arrhythmias or acute coronary syndromes.
Exercise testing
A standard bicycle exercise ramp protocol was used, with increments of 10 W/min. Details of the test protocol have been reported previously [12, 17] . Before each test, oxygen and carbon dioxide analysers and a flow mass sensor were calibrated by use of available precision gas mixtures and a 3-litre syringe respectively. To stabilize gas measurements, patients were asked to remain still for at least 3 min before beginning an upright graded bicycle exercise testing, using a continuous protocol, which was continued until exhaustion.
A 12-lead ECG was recorded continuously (MAX-1; Marquette Electronics). BP (blood pressure) was recorded every minute by a cuff sphygmomanometer. Indications to stop the test were exhaustion, dyspnoea, angina, ST-segment depression 3 mm, high-degree AV (arteriovenous) block or ventricular tachycardia five consecutive beats at a rate 120/min, new-onset atrial fibrillation or SBP (systolic BP) 260 mmHg, as well as a progressive decrease in BP.
Vo 2 ,Vco 2 (carbon dioxide production) andV E (minute ventilation) were measured by breath-by-breath gas analysis with the use of a computerized metabolic cart (V max 29; Sensormedics).
Vo 2peak was recorded as the mean value ofVo 2 during the last 30 s of the test and is expressed as ml · kg −1 of body weight · min −1 .Vo 2peak was measured and expressed as an absolute and percentage predicted value from the individual age-, gender-and body-weight-corrected mean normal values (% pVo 2 ). The %Vo 2peak was calculated for each patient using Wasserman's equation [17b] .
Vo 2 AT (Vo 2 at the anaerobic threshold) was determined by using the V-slope method [18] . Other considered parameters were: (i)Ve/Vo 2 ratio, (ii)Ve/Vco 2 ratio (Ve,Vco 2 andVco 2 in l/min); (iii)Ve/Vco 2 slope, calculated in every subject as the slope of the regression line relating toVe toVco 2 during exercise testing, with the exclusion of the final non-linear portion after the onset of acidotic drive to ventilation.
AVco 2 /Vo 2 ratio > 1.00 was selected for the definition of maximal exercise.
TheVe/Vco 2 slope was used as the main index of the ventilatory response to exercise. We defined EVR as ȧ Ve/Vco 2 slope 34 [19] . The ratio ofVe/Vco 2 slope tȯ Vo 2peak , suggested previously as a better predictor of prognosis than either variable alone [20] , was also analysed.
Doppler echocardiography
Doppler echocardiography was performed using a Phillips MS Sonos 5.500 D device equipped with a multiband 1.8-3.6 MHz probe. LVEF was measured by two expert operators blinded to the CPET results, according to the modified Simpson's biplane method [20a] , in the apical four-and two-chamber views. Biplane volumes were calculated from area tracings using the disc summation method (modified Simpson's rule). PAP (pulmonary systolic pressure) was calculated by means of right ventricular/right atrial gradient in patients with detectable tricuspid regurgitation (peak ventricular/atrial gradient + 8-10 mmHg). Transmitral flow velocity was determined using the pulsed-wave Doppler approach with a 2-4 mm sample volume placed at the mitral leaflet tips level in the apical four-chamber view. The transmitral pulsed-wave Doppler blood flow velocities were calculated off-line from five consecutive cardiac cycles to measure E (early diastolic peak velocity; in cm/s), A (late diastolic peak velocity; in cm/s), E/A ratio and E deceleration time (ms). A restrictive filling pattern was defined as the presence of an E/A ratio > 2.0 cm/s and an E deceleration time < 140 ms. In patients with atrial fibrillation, the restrictive filling pattern was defined by an E deceleration time < 140 ms calculated off-line from ten consecutive cardiac cycles. PLVEF was defined as LVEF 40 % [21] [22] [23] .
Measurement of BNP plasma levels
Before exercise testing, blood was collected by venipuncture from an antecubital vein after 10 min of rest in the sitting position. A point-of-care test (Triage BNP test; Biosite Diagnostics) was used, based on an immunofluorimetric assay for the quantitative determination of BNP in whole blood or plasma. Normality range values are 0-40 pg/ml. BNP concentrations were determined by nurses blinded to the CPET results.
Statistical analysis
Categorical variables are presented as numbers (percentage), and continuous variables as medians (interquartile range). Between-group differences were tested using a χ 2 test, Student's t test or non-parametric testing according to normal or non-normal variable distribution. A P value < 0.05 was considered statistically significant.
To determine the independent predictors of the primary combined end point of occurrence of death and hospital admission for major cardiovascular events, we entered variables significant by univariable analysis (P < 0.004 by Bonferroni correction) into a multivariable Cox proportional hazards model in sequential diagnostic blocks of clinical and laboratory, echocardiographic and CPET information to mimic the sequence of information obtained in clinical practice. Relevant covariates were selected through a forward selection procedure. HRs (hazard ratios) are presented with 95 % CIs (confidence intervals). Non-categorical variables were entered as continuous values, and HRs are expressed as risk/10-unit change. In the final model, clinically relevant cut-off values were also used. Differences between Kaplan-Meier event-free survival curves, according to the predefined cut-off values, were assessed using the log rank test.
All statistical tests were two-tailed. Results were analysed using SPSS 10 (Microsoft ® ).
RESULTS
Clinical features and laboratory findings of our population are described in Table 1 . Median age was 75 (72, 79) years, LV function was mildly reduced in this series of patients, with PLVEF found in 131 patients (59 %), and an EVR was present in 123 out of 220 patients (56 %).
During a median follow-up of 19 (10, 40) months, 68 patients were admitted at least once for worsening HF (n = 45), arrhythmias (n = 12) or acute coronary syndromes (n = 11), and 32 died (17 from progressive HF, nine from sudden death, four from other cardiovascular causes and two from cancer). Among patients with left bundle branch, 12 (5.4 %) underwent re-synchronization therapy. Using a time-to-first-event approach, overall 94 patients (43 %) achieved the study end point of death or hospital admission. The significant predictors of major events by univariable analysis (P value < 0.004 using Bonferroni correction; Table 2 ) were entered into multiple multivariable Cox proportional hazard models in a sequential approach. HRs and related 95 % CIs per 10-unit increments and according to clinically relevant cut-off values are shown in Table 3 .
In the first model, among five clinical, laboratory and echocardiographic variables, only renal dysfunction and higher BNP levels were predictive of the end point. In the final model, including four CPET parameters, only renal dysfunction and a steeperVe/Vco 2 slope were significantly associated with outcome.
Survival rates free from HF admission by the KaplanMeier method according to theVe/Vco 2 slope, BNP levels and renal dysfunction are shown in Figures 2-4 respectively.
DISCUSSION
The present prospective study is among the largest carried out to define, in a multimodal assessment, the additive prognostic role of CPET in an elderly population with mild-to-moderate HF and depressed or preserved LV function. Our results demonstrate that, in 'robust' elderly patients with HF able to perform maximal exercise, CPET is a crucial step in prognostic assessment and ventilatory parameters, which, together with evidence of renal dysfunction, has a key role in risk stratification over and beyond the level of LV function. In advanced age, morbidity, with its attendant impact on quality of life, is a relevant target for HF management beyond extension of life, so we chose to assess outcome Creatinine clearance (eGFR) was calculated using the Cockcroft-Gault equation. Log rank P value < 0.005.
in terms of hospital admissions for major cardiac events besides mortality: 43 % of the patients met, over a median period of 19 months, the combined end point. Renal dysfunction, an established risk factor for adverse outcome in HF [1, 2] , was a main independent prognostic predictor across the spectrum of ventricular impairment in our elderly population. This finding has important clinical implications: pharmacological management, focused on kidney protection to prevent or slow progression of renal impairment, may also prove valuable in improving the outcome in elderly patients with HF.
Our present results underline further the relevance of PLVEF-HF in the elderly: although LV function predicted outcome by univariate analysis, both renal dysfunction and BNP, a composite marker of systolic and diastolic function and neurohormonal activation [13] , had a stronger independent association with prognosis. Actually, the role of LVEF is far less important when morbidity, with its attending health care costs and detrimental impact on quality of life, is considered: in overt HF, event-free survival does not differ among patients with depressed or preserved LV function [3, [21] [22] [23] . Moreover, a recent clinical trial, which enrolled 556 patients with HF with both preserved (LFEF > 50 %) or reduced (LVEF < 50 %) systolic function [24] , demonstrated that PLVEF-HF had a higher 6-months mortality rate than patients with HF with depressed LVEF. These findings are also supported by another recent retrospective study [25] that showed a similar post-discharge mortality and hospitalization rate in patients with preserved (LVEF > 40 %) and reduced (LVEF < 40 %) LVEF. A heterogeneous aetiology, the high prevalence in the older population and the underuse of optimal pharmacological treatment are probably the main reasons accounting for the high morbidity and mortality rate in patients with PLVEF-HF and in the reduced prognostic significance of LVEF in this group of patients.
Our main aim in the present study was to assess the additive prognostic role of CPET, an established test for risk stratification in other clinical HF settings, in elderly patients who so far have been substantially neglected in the literature. Controversy still exists on the best ventilatory prognostic predictor in general [11] . Peak exercisė Vo 2 has been found to be superior in large series [8] and recent studies [26] , and the anaerobic threshold in other studies of younger patients with HF [27] . Other studies have stressed the optimal value of ventilatory efficiency as a marker of adverse outcome [10] [11] [12] 28] . Old age itself might well determine the differences in the definition of the most useful CPET parameters for outcome assessment. Peak exerciseVo 2 is known to be influenced, besides by age and gender, by co-morbidities and noncardiac factors, such as muscle deconditioning, motivation and anaemia, all highly prevalent in the elderly, and might, therefore, be less useful as a prognostic marker in this population, as highlighted by our present findings.V o 2 AT, an objective parameter of cardiopulmonary exercise capacity that can be derived from submaximal exercise testing found previously to be useful in predicting 6-month mortality [27] , could not be determined in approx. 15 % of our present study patients and was not independently associated with prognosis in this group.
To date, only three studies have analysed the prognostic value of CPET in patients of an age similar to ours [29] [30] [31] . Both Davies et al. [29] and Mejhert et al. [30] demonstrated in small series the prominent predictive role of theVe/Vco 2 slope, but their analyses were restricted to patients with SHF. In a larger study by Cicoira et al. [31] , among 102 patients with SHF or PLVEF-HF with a maximal CPET (RER > 1), bothVo 2peak and theVe/Vco 2 slope were predictors of mortality. The inclusion of subjects with hypertrophic or restrictive cardiomyopathy and dynamic flow obstruction, the different end point (death compared with mortality and morbidity) and the underuse of β-blockers (15 compared with 56 %) may explain the different prognostic weight of LVEF in the experiences obtained by Cicoira et al. [31] and ourselves in the present study. In none of the above studies was CPET compared with BNP as a risk stratification tool.
In a group of patients with SHF and a median age of 71 years, we have demonstrated previously the prognostic superiority of ventilatory and diastolic function parameters in comparison with BNP [17] . In the present study, although independently predictive in the clinical model as anticipated by its significant relationship with ventilatory parameters, BNP lost its power when ventilatory parameters, namely theVe/Vco 2 slope, were included in the multivariable model. On the basis of these findings, BNP may be used as a reliable surrogate predictor of prognosis when CPET cannot be adequately performed in the elderly.
The prognosis of elderly patients with HF is poor, and NYHA classification, a simple and widely used approach to the assessment of their functional status, appears unreliable for risk stratification.
CPET, an inexpensive and reliable tool for testing cardiopulmonary function, can be safely performed in the vast majority of older patients, adding important information on disease severity and, thus, also providing a guide for tailored HF treatment in this population normally neglected by exercise testing guidelines.
Study limitations
Our present study population was relatively small and included only clinically stable 'robust' outpatients with mild-to-moderate HF who did not have relevant co-morbidities and were, furthermore, able to perform CPET. Therefore our conclusions cannot be extended to all elderly patients with HF.
β-Blockers reduced mortality and hospital admissions in landmark HF trials, but did not predict outcome in the present study. One possible explanation is the relatively low proportion of sudden deaths with respect to worsening HF in our patients. Furthermore, stratification of ventilatory parameters by β-blocker treatment did not show any significant differences.
We did not measure plasma NT-pro-BNP (N-terminal pro-BNP), reported recently [32, 33] as an accurate prognostic predictor in HF, as point-of-care testing was not available for NT-pro-BNP at the time the study was performed. Patients with advanced renal dysfunction were excluded from the present study because of the nonspecific elevation of plasma BNP in this clinical condition; however, even in this relatively healthy population, mild degrees of renal dysfunction were one of the strongest predictors of outcome, independent of BNP levels.
We did not assess the value of other emerging ventilatory parameters, such as theVo 2 efficiency slope [34] . Indeed, others [28] have recently reasserted the superior prognostic characteristics of theVe/Vco 2 slope oveṙ Vo 2peak , both at maximal and submaximal testing, in younger patients with HF treated with β-blockers in a proportion similar to our present study.
Conclusions
In 'robust' elderly patients with mild-to-moderate HF and impaired function or PLVEF, reduced eGFR (estimated GFR) and a steeperVe/Vco 2 slope provide additional independent prognostic information across the spectrum of ventricular function and identify a high-risk population commonly not considered in exercise testing guidelines. These findings should extend some of the clinical applications of CPET validated in middle-aged patients to older populations with HF not eligible for heart transplantation, suggesting a wider use of this technique.
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